Did CVM provide update at HCW in Jan?
The link to the CVM presentation at the HC Wainwright BIOCONNECT conference in January where CVM presented, is no longer active. Did you get a chance to listen? If so, did they give more precise details on when they plan to read out their Phase 3 trial of Multikine in head & neck cancer? It appears imminent, but the company is pretty sparse and non-traditional with communications. Quite strange that communication is so sparse and non-traditional for a company that has a market cap of over $500M and has conducted a large phase 3 trial in head and neck cancer in my view. Plus, I get concerned when there are delays in data reporting. If the data was locked in December, shouldn't it have been reported by now? See our IQ card (HERE) on Multikine in cancer, and see their June 2020 presentation (HERE) for more details from the company.
$CVM #CVM #immuno_oncology #immunotherapy #cytokine_therapy #multikine